Entendiendo las terapias actuales en melanoma metastásico
Cutaneous melanoma is a highly aggressive tumor developing from melanocytes, its incidence is increasing, and prognosis in advanced stages is daunting. New therapies have been approved during the recent years with unprecedented results, including inhibitors of MAPK/ERK pathway and immune checkpoint...
Guardado en:
Autores principales: | Rodríguez,Rocío, Parra,Angela, González,Sergio, Molgó,Montserrat, Droppelmann,Nicolás, Acevedo,Francisco, Peña,José, Uribe,Pablo |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Médica de Santiago
2016
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872016001100011 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Melanoma metastásico con tumor primario oculto
por: Bórquez M,Pablo, et al.
Publicado: (2012) -
NUEVAS TERAPIAS SISTÉMICAS PARA EL TRATAMIENTO DEL MELANOMA
por: Droppelmann M,Nicolás, et al.
Publicado: (2016) -
A Case of Severe Diabetic Ketoacidosis Associated with Pembrolizumab Therapy in a Patient with Metastatic Melanoma
por: Wu L, et al.
Publicado: (2021) -
Sulforaphane enhances the antitumor response of chimeric antigen receptor T cells by regulating PD-1/PD-L1 pathway
por: Chunyi Shen, et al.
Publicado: (2021) -
Systemic treatments for metastatic cutaneous melanoma (Russian Translation of Cochrane Plain Language Summary – PLS)
por: Airat Usmanovich Ziganshin
Publicado: (2021)